Elinor Ben-Menachem
Institute for Clinical Neuroscience and Rehabilitation
Sahlgrenska Academy
Sahlgrenska University Hospital
Göteborg
Sweden
Name/email consistency: high
- Strategy for utilization of new antiepileptic drugs. Ben-Menachem, E. Curr. Opin. Neurol. (2008)
- Weight issues for people with epilepsy--a review. Ben-Menachem, E. Epilepsia (2007)
- Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Ben-Menachem, E., Edrich, P., Van Vleymen, B., Sander, J.W., Schmidt, B. Epilepsy Res. (2003)
- Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy. Ben-Menachem, E., Gilland, E. Seizure (2003)
- Predictors of weight loss in adults with topiramate-treated epilepsy. Ben-Menachem, E., Axelsen, M., Johanson, E.H., Stagge, A., Smith, U. Obes. Res. (2003)
- Preliminary efficacy of levetiracetam in monotherapy. Ben-Menachem, E. Epileptic. Disord (2003)
- Levetiracetam: treatment in epilepsy. Ben-Menachem, E. Expert. Opin. Pharmacother (2003)
- Vagus-nerve stimulation for the treatment of epilepsy. Ben-Menachem, E. Lancet. Neurol (2002)
- Proof of efficacy trials: seizure types. Ben-Menachem, E. Epilepsy Res. (2001)
- Vagus nerve stimulation, side effects, and long-term safety. Ben-Menachem, E. J. Clin. Neurophysiol (2001)
- Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Ben-Menachem, E., Kyllerman, M., Marklund, S. Epilepsy Res. (2000)
- Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Ben-Menachem, E., Falter, U. Epilepsia (2000)
- Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years. Ben-Menachem, E., Hellström, K., Waldton, C., Augustinsson, L.E. Neurology (1999)